License Required
Vaqta® Pediatric Hepatitis A Vaccine Indicated for People 12 Months Through 18 Years of Age 25 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL
00006409502 | USAMP#76273185
container type
volume
dosage form
strength
Secure Checkout
Verified Supply Chain
Priority Fulfillment
Locked
Base Price
$517.93
BX
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
- VAQTA is a sterile suspension for intramuscular injection
- One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
- Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride
